SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ICICI Securities Recommends Buying Thyrocare Technologies, Sets Rs 620 Target

The research report says Thyrocare delivered about 25% growth in revenue, EBITDA and PAT in Q2FY27.

THYROCARE

Related stories